Myoglobin Market by Product type (Human Myoglobin, Animal Myoglobin), By End User (Hospitals, Research Institutes, and Others), and Geography (North America, Latin America, Europe, Middle East and Africa and Asia Pacific)

 

Myoglobin Market size was valued at USD 98.2 billion in 2021, growing at a CAGR of 4.2% from  2022 to 2028. The global market provides a detailed overview of the global myoglobin market, and that can be segmented by product type and by end user. By product type, the global myoglobin market has been segmented into Human Myoglobin and Animal Myoglobin. The Human Myoglobin segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. Based on end user, the global myoglobin market is segmented into Hospitals, Research Institutes, and Others. The Hospitals segment accounts for the largest share in 2021 and is anticipated to register a significant CAGR in the upcoming years. Myoglobin act as a biomarker which is released into the blood stream if the heart is under stress or if the cardiac muscle gets damaged. Therefore, myoglobin is used as a bio-marker in cases of cardiac diseases. Due to the increase in awareness regarding cardiovascular diseases and the need of early diagnosis, increase in demand for myoglobin in laboratories across the globe are expected to propel the growth of the market. Moreover, the use of myoglobin in meat packaging process and strategic collaborations between the market players are expected to enhance the sales of the myoglobin market. However, the limited awareness regarding the uses of myoglobin is may hamper the growth of the market. Key Development: In Oct 2022, CytoSorbents Corporation announced the presentation of exciting new data on the use of CytoSorb in various cardiac surgery indications. In Dec 2021, Motif FoodWorks launched Hemami, heme binding protein which can deliver the flavour and aroma of real meat.